Cargando…
The Proteomics of Intrathecal Analgesic agents for Chronic Pain
Chronic pain remains a challenging clinical problem with a growing socio-economic burden for the state. Its prevalence is high and many of the patients are of work age. Our knowledge regarding the pathophysiology of chronic pain is poor. The consensus view is that the central nervous system plays a...
Autores principales: | Moore, David M., McCrory, Connail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412698/ https://www.ncbi.nlm.nih.gov/pubmed/26907496 http://dx.doi.org/10.2174/1570159X14666160224124446 |
Ejemplares similares
-
Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid
por: Royds, Jonathan, et al.
Publicado: (2020) -
The role of T-lymphocytes in neuropathic pain initiation, development of chronicity and treatment
por: Galvin, DA, et al.
Publicado: (2021) -
Analgesic Effect of Intrathecal Ginsenosides in a Murine Bone Cancer Pain
por: Yoon, Myung Ha, et al.
Publicado: (2010) -
Analgesic Effect of Intrathecal Gabapentin in a Rat Model of Persistent Muscle Pain
por: Kang, Tae-Wook, et al.
Publicado: (2014) -
Intrathecal betamethasone for cancer pain: A study of its analgesic efficacy and safety
por: Taguchi, Hitoshi, et al.
Publicado: (2018)